Выбор редакции

China hands drugmaker GSK record $489 million fine, sentences executives

BEIJING (Reuters) - China has fined GlaxoSmithKline Plc a record 3 billion yuan ($488.8 million) for paying bribes to doctors to use its drugs, the British company said on Friday, drawing to a close a corruption probe that rocked the pharmaceutical sector in China.